Arrowstreet Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-145,080
| Closed | -$753K | – | 2027 |
|
|
2024
Q3 | $753K | Buy |
+145,080
| New | +$753K | ﹤0.01% | 1451 |
|
|
2020
Q4 | – | Sell |
-108,195
| Closed | -$2.72M | – | 2590 |
|
|
2020
Q3 | $2.72M | Buy |
+108,195
| New | +$2.72M | ﹤0.01% | 1431 |
|
|
2015
Q1 | – | Sell |
-12,161
| Closed | -$206K | – | 1258 |
|
|
2014
Q4 | $206K | Buy |
+12,161
| New | +$206K | ﹤0.01% | 1184 |
|